JPH02243632A - Peroxide lipid formation inhibitor comprising vegetable oil extract - Google Patents
Peroxide lipid formation inhibitor comprising vegetable oil extractInfo
- Publication number
- JPH02243632A JPH02243632A JP1064744A JP6474489A JPH02243632A JP H02243632 A JPH02243632 A JP H02243632A JP 1064744 A JP1064744 A JP 1064744A JP 6474489 A JP6474489 A JP 6474489A JP H02243632 A JPH02243632 A JP H02243632A
- Authority
- JP
- Japan
- Prior art keywords
- water
- ratio
- mixed solvent
- extracted
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 Peroxide lipid Chemical class 0.000 title claims abstract description 42
- 239000003112 inhibitor Substances 0.000 title claims abstract description 14
- 239000000284 extract Substances 0.000 title abstract description 27
- 230000015572 biosynthetic process Effects 0.000 title abstract description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 title 1
- 239000008158 vegetable oil Substances 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 20
- 244000269722 Thea sinensis Species 0.000 claims abstract description 14
- 239000012046 mixed solvent Substances 0.000 claims abstract description 14
- 229940058015 1,3-butylene glycol Drugs 0.000 claims abstract description 10
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 10
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 9
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 7
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 7
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 5
- 240000006891 Artemisia vulgaris Species 0.000 claims abstract description 5
- 235000009569 green tea Nutrition 0.000 claims abstract description 5
- 239000000419 plant extract Substances 0.000 claims abstract 3
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 2
- 238000000605 extraction Methods 0.000 claims description 38
- 239000002904 solvent Substances 0.000 claims description 27
- 238000004519 manufacturing process Methods 0.000 claims description 25
- 239000007858 starting material Substances 0.000 claims description 8
- 235000006468 Thea sinensis Nutrition 0.000 claims description 5
- 235000020279 black tea Nutrition 0.000 claims description 5
- 240000005809 Prunus persica Species 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 15
- 244000105059 Geranium thunbergii Species 0.000 abstract description 6
- 235000005491 Geranium thunbergii Nutrition 0.000 abstract description 6
- 244000223014 Syzygium aromaticum Species 0.000 abstract description 6
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 4
- 235000013616 tea Nutrition 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 244000299492 Thespesia populnea Species 0.000 abstract 1
- 235000009430 Thespesia populnea Nutrition 0.000 abstract 1
- 244000081822 Uncaria gambir Species 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 30
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 13
- 239000002537 cosmetic Substances 0.000 description 10
- 238000009472 formulation Methods 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000736199 Paeonia Species 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 229920005862 polyol Polymers 0.000 description 5
- 150000003077 polyols Chemical class 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000001678 irradiating effect Effects 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000010802 sludge Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 208000024963 hair loss Diseases 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000269837 Artemisia dubia Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000008474 Pimenta dioica Species 0.000 description 2
- 235000006990 Pimenta dioica Nutrition 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241001529742 Rosmarinus Species 0.000 description 2
- 241001072909 Salvia Species 0.000 description 2
- 235000017276 Salvia Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 240000004731 Acer pseudoplatanus Species 0.000 description 1
- 235000002754 Acer pseudoplatanus Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 235000006485 Platanus occidentalis Nutrition 0.000 description 1
- 241000183024 Populus tremula Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000013142 basic testing Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
(イ)発明の目的
本発明は植物(和漢植物)をもとに、過酸化脂質の生成
に対して、抑制する作用をもった成分の検索を通じて、
その中から特に優れた抑制作用を持った成分を過酸化脂
質の抑制剤として応用することを目的となす。[Detailed Description of the Invention] (a) Purpose of the Invention The present invention aims to find ingredients based on plants (Japanese and Chinese plants) that have the effect of suppressing the production of lipid peroxides.
The purpose of this study is to apply components with particularly excellent inhibitory effects as lipid peroxide inhibitors.
その結果、本発明にあっては、A:茶の葉(緑茶、紅茶
)、B:シャクヤク、C:ヨモギ、D:チョウジ、E:
ゲンノショウコ、F:7センヤク、G:オウバク、H:
モモの葉が原料となり。As a result, in the present invention, A: tea leaves (green tea, black tea), B: peony, C: mugwort, D: clove, E:
Gennoshoko, F: 7 Senyaku, G: Oubaku, H:
The raw material is peach leaves.
抽出溶液を特定して得られた。それぞれのA−Gにかか
るエキスをもって、新規、過酸化脂質の抑制剤となすも
のである。The extraction solution was identified and obtained. The extracts of each of A to G are used as a novel lipid peroxide inhibitor.
尚、上記したそれぞれの植物超厚は、B:シャクヤク、
D:チョウジ、F:アセンヤク、G:オウバクの使用部
位は、日本薬局方に定められた超厚のもの、A:茶の葉
は、日頃、飲用されるために加工された製茶、C:ヨモ
ギとE:ゲンノショウコは2それぞれ葉、および茎、H
:モモの葉は、その小枝が含まれていても差し支又はな
い。In addition, the ultra-thickness of each of the above-mentioned plants is B: Peony;
D: cloves, F: aspen yakuza, G: the parts used are those that are extremely thick as stipulated by the Japanese Pharmacopoeia, A: tea leaves processed for daily drinking, C: mugwort and E: Gennoshoko has two leaves and stem, H
: Peach leaves may contain twigs.
「産業上の利用分野」
上記に示した特定された植物A〜Hをもとに、特定され
た混合溶媒中で溶出(抽出)して得られたエキスは、そ
れぞれに過酸化脂質の生成を顕著に抑制することから、
例えば、化粧水、又はクリームや乳液、その他の剤形の
、肌や頭髪に使用される。化粧品中に配合して用いるこ
とが出来る。"Industrial Application Field" The extracts obtained by elution (extraction) in the specified mixed solvents based on the specified plants A to H shown above are capable of producing lipid peroxides. Because it significantly suppresses
For example, it is used for skin and hair in the form of lotions, creams, emulsions, and other formulations. It can be used by blending it into cosmetics.
又、さらに飲料として、あるいは加工食品などに配合す
ることも出来る。Furthermore, it can be added to beverages or processed foods.
さらに1本発明による抽出エキスを処方中に配合すると
、処方中に含まれた脂質成分の酸化を防ぎ、安定化に寄
与するとともに、これを塗布すれば、肌や毛髪組織内の
脂質、更に、服用(飲用)すれば、それによって1体内
の過酸化脂質の異常な高まりによって起こる、さまざま
な症状の改善効果が期待出来る。Furthermore, when the extract according to the present invention is added to a formulation, it prevents the oxidation of the lipid components contained in the formulation and contributes to stabilization. If taken (drinked), it can be expected to improve various symptoms caused by an abnormal increase in lipid peroxide in the body.
「従来の技術」
植物中から得られた抽出物(エキス)を、化粧料や加工
食品、あるいは医薬品等の分野に応用することは、古く
から知られているが、植物由来の抽出物から、過酸化脂
質の生成を抑制することのできる成分の検索とその利用
法については、ごく最近になって注目されてるようにな
って来ている。その理由の1つとしては、生体内におけ
るスーパーオキサイドジスムターゼ(50D)の発見以
来、生体の酸化・還元による代謝機構が、より明らかに
なってきたことが上げられる。"Conventional technology" It has been known for a long time that extracts obtained from plants can be applied to fields such as cosmetics, processed foods, and pharmaceuticals. The search for ingredients that can suppress the production of lipid peroxides and their uses have only recently been attracting attention. One of the reasons for this is that since the discovery of superoxide dismutase (50D) in living organisms, the metabolic mechanism of living organisms through oxidation and reduction has become clearer.
例えば、生体における脂質が、過剰な酸化脂質の異常に
進んだ状態にあっては、肝機能障害、痴呆症、動脈硬化
症などの引き金の1つとなっていると考えられているこ
と。For example, when lipids in the living body are in an abnormally advanced state with excessive oxidized lipids, it is thought to be one of the triggers of liver dysfunction, dementia, arteriosclerosis, etc.
又、肌や髪にあっては、過酸化脂質の皮膚組織内や皮脂
分泌量の増加が長期にわたれば、それは、正常な肌や髪
の成長を妨げ、フケ、カユミ、肌荒れ、脱毛、シラガな
どの、いわゆる老化現象を促進し、更に肌では1色素メ
ラニンの沈着による。シミの発生を促進する原因となっ
ているものなど、組繊細胞学的な角度、臨床学的な角度
から推定される様になってきている。In addition, when it comes to skin and hair, if the lipid peroxide in the skin tissue and the increase in sebum secretion continue for a long period of time, it will interfere with normal skin and hair growth, causing dandruff, itching, rough skin, hair loss, and hair loss. It promotes the so-called aging phenomenon, and is also caused by the deposition of one pigment, melanin, in the skin. The factors that promote the development of age spots are being estimated from a cytological and clinical perspective.
さらに、植物由来成分の過酸化脂質生成抑制作用をもっ
た成分(エキス)やSODを、すでに化粧品等の分野に
応用することが、活発に進められているが1例^ば、そ
れらの開発状況に付いて、調査すれば、次表「第1表」
に示すごと(の公開特許公報がある。Furthermore, active efforts are already being made to apply plant-derived ingredients (extracts) and SOD that have the effect of inhibiting lipid peroxide production to cosmetics and other fields. If you investigate, you will find the following table "Table 1"
There is a published patent publication as shown in ().
尚、第1表中、そのNO,1〜2ば、SODの応用につ
いての公報の所在について示しているが。In Table 1, numbers 1 and 2 indicate the location of publications regarding the application of SOD.
SODはヒトをはじめ、各種の動・植物、微生物の生体
中に存在し、生体内においては、過剰に生成された活性
酸素、Q、l−1に対して、捕捉除去:スカベンジャー
としての働きを何している特殊な酵素として注目され、
化粧品等へのSODの応用が行なわれ、処方中の脂質や
、皮膚表皮上に分泌される皮脂の過酸化脂質の抑制、肌
や毛髪のケラチン蛋白構造の変性劣化の防止、シミ、シ
ワ、脱毛等の老化現象の予防等の効果が期待され、とく
に外出時の紫外1](日光)による、肌や毛髪の日焼け
による炎症(紅BI)の抑制1色素性着の予防効果が期
待されている。SOD exists in the living bodies of various animals, plants, and microorganisms, including humans, and in living bodies, it acts as a scavenger to capture and remove excessively produced active oxygen, Q, and l-1. It has attracted attention as a special enzyme,
SOD has been applied to cosmetics, etc., to suppress lipids in prescriptions and lipid peroxides in sebum secreted on the skin epidermis, to prevent degeneration and deterioration of the keratin protein structure of skin and hair, to prevent spots, wrinkles, and hair loss. It is expected to be effective in preventing aging phenomena such as 1), and in particular to suppress inflammation (red BI) caused by sunburn on the skin and hair caused by ultraviolet 1] (sunlight) when going out.1) It is expected to be effective in preventing pigmentation. .
一方、第1表のN003には、その公報に記載された。On the other hand, No. 003 in Table 1 was described in that publication.
植物由来の抽出物の中から、過酸化脂質の生成を抑制す
るものを拾い上げたものであるが、該当する植物名のな
かでも、とくにアンダーラインを付した、ローズマリー
、サルビア、オールスパイス、パプリカ、胡麻、タイム
から得られた抽出物が好ましいとある。Among plant-derived extracts, we selected those that suppress the production of lipid peroxides, and among the relevant plant names, we particularly selected the underlined ones: rosemary, salvia, allspice, and paprika. , sesame, and thyme are preferred.
さらに、それらの抽出溶媒としては、いろいろな有機溶
媒を用いることが開示されているが、具体的には、ロー
ズマリー、サルビア、オールスパイスを出発原料とする
際の抽出溶媒としては、アセトンを用いた単独溶媒によ
り得られた抽出物について開示されており、さらに、こ
のアセトンによる抽出物については、特定の界面活性剤
とエタノールとの混液や、あるいは、界面活性剤に、カ
ルボキシメチルポリマーを加えてゲル状化したもの、軟
膏として製剤化した例が示されている。Furthermore, it has been disclosed that various organic solvents are used as extraction solvents, but specifically, acetone is used as an extraction solvent when rosemary, salvia, and allspice are used as starting materials. Furthermore, the extract obtained using acetone is disclosed in a mixture of a specific surfactant and ethanol, or by adding a carboxymethyl polymer to the surfactant. Examples of formulations such as gels and ointments are shown.
「第1表」刊行物の所在
「発明が解決しようとする課題」
本発明者らは、天然産物の有効利用をテーマとなし、各
種の植物組織中から、過酸化脂質の生成抑制作用を有す
る成分の検索に当ってきた。"Table 1" Location of Publications "Problems to be Solved by the Invention" The present inventors have focused on the effective use of natural products, and have discovered that they have the ability to inhibit the production of lipid peroxides from various plant tissues. I've been searching for ingredients.
すなわち、植物のみならず、動物、微生物など、あらゆ
る生物の営みにあって、過酸化脂質の生成を抑制する物
質は、その強弱の差はあっても、必ず存在するといって
も過言ではない。In other words, it is no exaggeration to say that in the activities of all living things, including not only plants but also animals and microorganisms, there are always substances that suppress the production of lipid peroxide, although there may be differences in their strength.
したがって1本発明における解決すべき問題点としでは
、次の如く集約できる。Therefore, the problems to be solved by the present invention can be summarized as follows.
1:先ず第1が過酸化脂質作用の測定試験をもとにして
、その作用の強弱について、多種多様の植物組織(出発
原料)からの検索(スクリーニング)。1: First, based on a test to measure the action of lipid peroxide, a wide variety of plant tissues (starting materials) are searched (screened) for the strength or weakness of the action.
2:次が、その収率(収量)性。2: Next is its yield (yield).
3:そして、同時に安定性が悪いものでは、配合上、好
ましくはない。3: At the same time, if the stability is poor, it is not preferable in terms of formulation.
4:さらに、欲をいえば、例えば、化粧水や飲料水など
の系中にあって汎用される原料中、少なくとも、(イ)
水、(ロ)エタノール、(ハ)ポリオール溶媒(グリセ
リン、プロピレングリコール、1.3−ブチレングリコ
ールなど)のいずれかに、可溶性であることが望まれる
。4: Furthermore, for example, among the raw materials commonly used in systems such as lotions and drinking water, at least (a)
It is desired that it be soluble in either water, (b) ethanol, or (c) polyol solvents (glycerin, propylene glycol, 1,3-butylene glycol, etc.).
以上、4つの条件を満たすことが可能な抽出物が発見で
きたならば、それは本発明の目的が達成されたことにな
る。If an extract that can satisfy the above four conditions is discovered, it means that the object of the present invention has been achieved.
しかし、多くの植物を相手に、上記した4つの事柄につ
いて、そのすべてに満足するものとなると、それは極め
て少なかったと述べても過言ではない。However, it is no exaggeration to say that when dealing with a large number of plants, it is extremely rare to be satisfied with all of the above four conditions.
例λば、スクリーニングの基礎的な試験の段階にあって
は、出発原料に対して、抽出に用いる溶剤の選択の違い
は、それによって得られた抽出物の効果、すなわち、目
的となす、過酸化脂質の抑制作用の強弱に大きく差かつ
(ことである。For example, at the basic testing stage of screening, differences in the selection of solvents used for extraction with respect to the starting materials are important in determining the effectiveness of the resulting extract, i.e., the desired There is a big difference in the strength of the inhibitory effect of oxidized lipids.
そこで、本発明者らは、先ず1本発明に当っては、あら
かじめ、前記した(イ)〜(ロ)の3つの溶媒に的を絞
り込み、様々な植物をもとに、植物の葉、茎、根などの
部位を主体に、検索を開始したのである。Therefore, in developing the present invention, the present inventors first narrowed down their focus to the three solvents (a) to (b) mentioned above, and based on various plants, the leaves and stems of plants were used. , and began searching mainly for parts such as roots.
その結果9始めに述べた如く、A〜Hで示す植物生薬、
または、民間生薬から得られた抽出物(エキス)をもっ
て1本発明を成功するに至ったのである。As a result, as mentioned at the beginning of 9, the herbal medicines shown by A to H,
Alternatively, the present invention was successfully accomplished using extracts obtained from folk medicines.
(口〉発明の構成
本発明は、A:li茶または紅茶、B:シャクヤク、C
:ヨモギ、D=チョウジ、E:ゲンノショウコ、F:ア
センヤク、G:オウバク、H:モモの葉を出発原料とな
し、そのA〜Hのそれぞれに対する抽出溶媒が、以下に
示す混合溶媒を用いて抽出(溶出)されたエキスの内、
その1種、又は1種以上を含有することを特徴とする。(mouth) Structure of the invention The present invention consists of A: li tea or black tea, B: peony, C
: Mugwort, D = Clove, E: Gennoshoko, F: Asperianium, G: Peach leaf, H: Peach leaves are used as the starting material, and the extraction solvent for each of A to H is extracted using the mixed solvent shown below. Among the (eluted) extracts,
It is characterized by containing one or more of them.
過酸化脂質生成抑制剤に特定される。Specified as a lipid peroxide production inhibitor.
抽出溶媒は、出発原料植物によって異なり、A−Bに対
する抽出溶媒は、水とエタノール、及び1.3−ブチレ
ングリコールの割合が、5対3対2から3対3対4の混
合溶液を用いること。The extraction solvent varies depending on the starting material plant, and the extraction solvent for A-B is a mixed solution of water, ethanol, and 1,3-butylene glycol in a ratio of 5:3:2 to 3:3:4. .
C^Gに対する抽出溶媒は、水とエタノールの割合が、
7対3から4対6の混液を用いること。The extraction solvent for C^G is such that the ratio of water and ethanol is
Use a mixture of 7:3 to 4:6.
Hに対する抽出溶媒としては、水と1.3−ブチレング
リコールの割合が、6対4から3対7の混合溶液を用い
ることである。As the extraction solvent for H, a mixed solution of water and 1,3-butylene glycol in a ratio of 6:4 to 3:7 is used.
「課題を解決するための手段」
上記に特定した本発明について、更に具体的に示すため
に、以下に抽出例、実験法(スクリーニング)と共に、
その成績結果(データ)を開示して、更に詳細に述べる
と、次の如くである。"Means for Solving the Problems" In order to more specifically illustrate the present invention specified above, the following is an example of extraction and an experimental method (screening).
The results (data) will be disclosed and described in more detail as follows.
「抽出法l」
(植物超厚:A〜Hの製造例)
出発原料が、A:緑茶または紅茶、B:シャクヤクつい
ては、それぞれ、個々に重量1部に対し、抽出溶媒とし
て、水とエタノール、及びl、3−ブチレングリコール
の割合が、5対3対2から、3対3対4の混合溶媒を5
〜15部(抽出操作上、好ましくは、10部)を用いて
浸漬後、圧搾して得られた抽出溶液を粗液となし、ろ過
後の溶液を、そのままか、適宜、1liiした溶液の形
態か、あるいは乾燥パウダー化して、過酸化脂質生成に
対する抑制剤となす。"Extraction method 1" (Production examples of plant super thick: A to H) When the starting materials are A: green tea or black tea, B: peonies, water and ethanol are used as extraction solvents for 1 part by weight of each. and l,3-butylene glycol in a ratio of 5:3:2 to 3:3:4.
The extracted solution obtained by immersion and squeezing with ~15 parts (preferably 10 parts for extraction operation) is used as a crude liquid, and the solution after filtration is used as it is or as appropriate. Alternatively, it can be made into a dry powder to act as an inhibitor against lipid peroxide formation.
「抽出法2」
(植惣超厚:C−Gの製造例)
出発原料が、C:ヨモギ、D:チョウジ、E:ゲンノシ
ョウコ、F:アセンヤク、G:オウバクであるときは、
それぞれ、個々に重量1部に対し、抽出溶媒として、水
とエタノールの割合が、7対3から4対6の混合溶媒を
5〜15部(抽出操 作土、好ましくは、10部)を用
いて浸漬後、圧搾して得られた抽出溶液を粗液となし、
ろ過後の溶液を、そのままか、適宜、濃縮した溶液の形
態か、あるいは乾燥パウダー化して、過酸化脂質生成に
対する抑制剤となす。"Extraction method 2" (Manufacturing example of Ueso super thick: C-G) When the starting materials are C: mugwort, D: clove, E: gennoshoko, F: asenyaku, G: sycamore,
For each part by weight, 5 to 15 parts (extraction soil, preferably 10 parts) of a mixed solvent of water and ethanol in a ratio of 7:3 to 4:6 are used as the extraction solvent. After soaking, the extracted solution obtained by squeezing is used as a crude liquid,
The solution after filtration is used as an inhibitor against lipid peroxide production, either as it is, in the form of an appropriately concentrated solution, or in the form of a dry powder.
この際、ろ過した溶液あるいは、適宜、濃縮した溶液に
対して、更に、使用分野に応じて例えば、l、3−ブチ
レングリコール、プロピレングリコール、グリセリンな
どのポリオール系の溶媒などを、適当量添加して製品と
してもよい。At this time, an appropriate amount of a polyol solvent such as 1,3-butylene glycol, propylene glycol, or glycerin may be added to the filtered solution or the appropriately concentrated solution depending on the field of use. It may also be used as a product.
又、前記の(抽出法1〜2)における工程中にあって、
それぞれに得られたA−G由来の抽出溶液について、乾
燥パウダー化する場合には、減圧濃縮(真空濃縮)、凍
結乾燥、噴霧乾燥などの方法により行い、長時間わたる
高温加熱にさらされるような乾燥は、避けることが望ま
しい。Also, during the steps in the above (extraction methods 1 to 2),
When converting the A-G-derived extract solutions obtained in each case into dry powder, use methods such as reduced pressure concentration (vacuum concentration), freeze drying, and spray drying. It is desirable to avoid drying.
又、乾燥パウダー化する際には、適宜5他の賦形剤、結
合剤1例えば、デキストリン、各種の植物性由来のデン
プン類、あるいは、それらの水溶性の多糖体を加えてパ
ウダー化(製品)して用いても良い。In addition, when dry powdering, 5 other excipients, binders 1, etc., such as dextrin, various vegetable starches, or water-soluble polysaccharides thereof, are added as appropriate to powder (product ) may also be used.
尚、この場合、パウダー化した製品では、そのパウダー
中の水分の含量は、12%以下が望ましくは、7〜8%
以下に仕上げ、湿気を吸収しない容器に保存することに
よって、長期間にわたり安定性が保持される。In this case, in the case of a powdered product, the water content in the powder is preferably 12% or less, preferably 7 to 8%.
Stability is maintained over long periods of time by finishing the product as follows and storing it in a container that does not absorb moisture.
「抽出法3」
(植物起R:Hの製造例)
H:モモの葉からの抽出にあっては、その抽出溶媒とし
ては、水と1.3−ブチレングリコールの割合が、6対
4から3対7の混合溶媒を用いることによって、以下、
その他の工程は前記(抽出法1〜2)と同様にして、抽
出された溶液をろ過し、必要によっては、さらに濃縮し
た溶液となして、これを過酸化脂質の生成抑制剤となす
。"Extraction method 3" (Example of production of plant-based R:H) When extracting from H: peach leaves, the ratio of water and 1,3-butylene glycol is from 6 to 4 as the extraction solvent. By using a 3:7 mixed solvent, the following:
The other steps are the same as those described above (extraction methods 1 and 2), and the extracted solution is filtered, and if necessary, a further concentrated solution is prepared, and this is used as a lipid peroxide production inhibitor.
上記工程(抽出法3)により抽出された溶液は、前記(
抽出法1〜2)゛に示したととくのパウダー化して用い
ることもできるが、化粧料に用いる際には、通常は、溶
液の形態で各種の化粧料に任意な量を容易に配合できる
ため、肌用の化粧品から頭髪用化粧品まで1幅広く利用
することができ、とくに頭髪用のシャンプーやリンス剤
などにも容易に添加できる。The solution extracted by the above step (extraction method 3) is
Although it can be used in the form of powder as shown in Extraction Methods 1 and 2), when used in cosmetics, it is usually in the form of a solution because it can be easily blended into various cosmetics in any desired amount. It can be used in a wide range of applications, from skin cosmetics to hair cosmetics, and can be particularly easily added to hair shampoos and conditioners.
尚1食品や飲料用、化粧料に用いる場合の抽出溶媒の組
合せについては、上記(抽出法3)の工程中では、水と
1.3−ブチレングリコールの混合溶媒を使用したが、
1.3−ブチレングリコールをプロピレングリコールに
変えて、水とプロピレングリコールの割合が、6対4か
ら3対7の混合溶媒を用いて抽出された溶液を使用する
ことも出来る。Regarding the combination of extraction solvents when used in foods, beverages, and cosmetics, a mixed solvent of water and 1,3-butylene glycol was used in the process of the above (extraction method 3).
It is also possible to use a solution obtained by replacing 1.3-butylene glycol with propylene glycol and using a mixed solvent of water and propylene glycol in a ratio of 6:4 to 3:7.
[抽出溶媒の組合せ(割合)の検討結果」前記の抽出法
1〜3の方法によれば、そのいずれもが、目的となす優
れた過酸化脂質の生成抑制剤となすことが出来るわけで
あるが、さらに。[Results of examination of combinations (ratios) of extraction solvents] According to the above-mentioned extraction methods 1 to 3, all of them can serve as the desired excellent lipid peroxide production inhibitor. But further.
ここでは、各々の植物超厚=A〜Hに対応して。Here, corresponding to each plant superthickness = A to H.
最も過酸化脂質の生成抑制能が強く、安定性が良好であ
る溶液となすのか、この点を、本発明に採用した抽出溶
媒との関係から求めてみると、以下に示す如くである。The question of which solution has the strongest ability to inhibit lipid peroxide production and has the best stability is determined from the relationship with the extraction solvent employed in the present invention, as shown below.
A:緑茶&紅茶とB:シャクヤクの場合では。In the case of A: green tea & black tea and B: peonies.
共に水とエタノール、!、3−ブチレングリコールとの
割合が、5対3対2付近。Both water and ethanol! , the ratio with 3-butylene glycol is around 5:3:2.
C:ヨモギ、D=チョウジ、E:ゲンノショウコ、F:
アセンヤク、G:オウバクの場合では。C: Mugwort, D = Clove, E: Gennoshoko, F:
Asenyaku, G: In the case of Oubaku.
水とエタノールとの割合が、7対3付近。The ratio of water to ethanol is around 7:3.
H:モモの葉の場合では、水とポリオール系の溶剤との
混合割合は、過酸化脂質の生成抑制能から求めてみると
、!3よそ水が6に対して1両ポリオール系の溶剤(1
,3−ブチレングリコール、プロピレングリコール)の
割合は、4の付近にあるときが、最も強い状態の溶液と
することが出来る。H: In the case of peach leaves, the mixing ratio of water and polyol solvent can be determined from the ability to suppress the production of lipid peroxide! 3 parts water to 6 parts polyol solvent (1 part)
, 3-butylene glycol, propylene glycol) is around 4, the solution can be in its strongest state.
又、抽出法3により得られた過酸化脂質の生成抑制剤(
溶液)を、食用(飲料用)として用いるには、水とポリ
オール系の溶剤としては、プロピレングリコールに変え
て使用すると良い。In addition, the lipid peroxide production inhibitor obtained by extraction method 3 (
In order to use the solution as food (drinkable), it is preferable to use water and propylene glycol as the polyol solvent.
「過酸化脂質生成抑制作用(効果)の確認j(a)試験
方法
本発明における作用/効果の確認には1次の如くの試験
条件下で実施した。"Confirmation of lipid peroxide production inhibiting action (effect) j (a) Test method In order to confirm the action/effect of the present invention, testing was carried out under the following test conditions.
0.8%ラウリル硫酸ナトリウム水溶液に0.1%リル
ン酸溶液を加えて溶解し1次に。A 0.1% lyric acid solution was added to a 0.8% sodium lauryl sulfate aqueous solution to dissolve it.
この溶液を3.9mβ取り、これに適当な濃度にした、
各種の抽出物溶液「検体」を、0.1rnρ加えた後、
その溶液に対して、紫外線(東芝製ランプ:FL−20
SE lamp、FL−20SBLB lampを
それぞれ3灯並列灯火、照射距離:15cm)を1時間
照射してから、この液を1+r+12取り、次に、0.
8%チオバルビッール酸(丁B^)水溶液1.5rnI
2と20%酢酸(pH3,5)1.5mj2を加えた後
、95℃で1時間過熱する。冷浸、精製水1mI2及び
n−ブタノール:ピリジン(15: l)5mI2を加
えて、よ(振り、遠心分離機にかけて、n−ブタノール
層の532nmの吸光度を測定して、生成された過酸化
脂質の量を測定する。Take 3.9mβ of this solution and adjust it to an appropriate concentration.
After adding 0.1rnρ of various extract solutions “specimen”,
Apply ultraviolet light (Toshiba lamp: FL-20) to the solution.
After irradiating 3 SE lamps and FL-20SBLB lamps (3 lights in parallel, irradiation distance: 15 cm) for 1 hour, take this liquid at 1+r+12, and then apply 0.
8% thiobarbylic acid (Ding B^) aqueous solution 1.5rnI
After adding 1.5 mj2 of 20% acetic acid (pH 3,5), the mixture was heated at 95°C for 1 hour. Cool, add 1 ml of purified water and 5 ml of n-butanol:pyridine (15: 1), shake, centrifuge, and measure the absorbance of the n-butanol layer at 532 nm to determine the amount of lipid peroxide produced. measure the amount of
尚、検体を加えて紫外線を照射した場合の過酸化脂質量
をa、検体を加えて紫外線を照射しない場合の過酸化脂
質量をb、検体を加えないで紫外線を照射した場合の過
酸化脂質をa°検体を加えないで紫外線を照射しない場
合の過酸化脂質をboとし、a−b及びa’ −b’
を過酸化脂質生成量として9次式より抑制率を求める。In addition, the amount of lipid peroxide when adding a sample and irradiating ultraviolet rays is a, the amount of lipid peroxide when adding a sample and not irradiating ultraviolet rays, and the amount of lipid peroxide when irradiating ultraviolet rays without adding a sample. a ° Lipid peroxide when no sample is added and no ultraviolet rays are irradiated is bo, a-b and a'-b'
The suppression rate is determined from the 9th order equation, where is the amount of lipid peroxide produced.
本発明において採用した方法は、−数的には、TBA法
と呼ばれている定量法であるが、その詳細はついては1
次の文献(雑誌)に示されている。The method adopted in the present invention is a quantitative method numerically called the TBA method, and its details are described in 1.
It is shown in the following literature (magazine).
(TBA法に関する文献所在)
アナリテカル、バイオケミストリーv02゜95、p3
51〜358.(1979年)(b)効果/過酸化脂質
生成抑制作用
上記試験法をもとに、検索を続けた結果1本発明では、
前記したようにA〜Hの植物超厚を特定すると共に、そ
れぞれに、最もふされしい抽出溶媒の選択ができたので
ある。(References related to TBA method) Analytical, Biochemistry v02゜95, p3
51-358. (1979) (b) Effect/Inhibition of lipid peroxide production As a result of continued searching based on the above test method, 1. In the present invention,
As mentioned above, we were able to specify the ultra-thickness of plants A to H and select the most suitable extraction solvent for each.
次表「第2表」は、本発明にかかる抽出物(製造法:抽
出法1〜3)の工程において、粗抽出溶液をもとに、ろ
過して得られた溶液について、前記(a)の試験法を用
いて、その系中に添加する濃度を、25.12,5.2
.5μlの3段階により測定した時の成績結果について
示したものである。尚、「第2表」中には9本試験に用
いた各溶液に含まれる成分の量:エキス分の濃度を把渥
するために、その1つの指標として、「蒸発残分」の欄
を設け、その測定値を示してみたが。The following table "Table 2" shows the solutions obtained by filtering the crude extract solution in the process of producing the extract (manufacturing method: extraction methods 1 to 3) according to the present invention (a). Using the test method of 25.12, 5.2, the concentration added to the system was
.. The results are shown when measurements were performed using 5 μl in three stages. In addition, in "Table 2", in order to understand the amount of components contained in each solution used in the nine tests: the concentration of the extract component, the column "Evaporation residue" is included as one indicator. I set it up and showed the measured values.
ここで特定した。A〜H植物由来の抽出物は、いずれも
、極めて微量の濃度で、共に、過酸化脂質の生成に対す
る抑制作用が強いことが、確認できるわけである。identified here. It can be confirmed that all of the extracts derived from plants A to H have a strong inhibitory effect on the production of lipid peroxide even at extremely small concentrations.
「第2表」過酸化脂質の生成に対する抑制能(c)保存
安定性
前記、第2表中において、蒸発残分を示した、それぞれ
のA〜Hから得られた抽出溶液は、長期間にわたって、
オリや沈殿物の発生も極めて少ない状態にあり、その安
定性は、良好である。"Table 2" Ability to inhibit the production of lipid peroxide (c) Storage stability In Table 2 above, the extract solutions obtained from each of A to H, which showed the evaporation residue, remained for a long period of time. ,
There is very little generation of sludge or precipitates, and the stability is good.
しかし、これらの外観上の安定性と共に、長期間にわた
って保存された溶液が、その後、はたして、過酸化脂質
の生成を抑制する能力が残存し。However, along with these apparent stability, solutions stored for a long period of time still have the ability to suppress the formation of lipid peroxides.
発揮する力を有しているだろうか。Do you have the power to do so?
例えば、はじめに紹介したような、公知な過酸化脂質の
抑制作用が知られているものの中には、抽出後の溶液が
、短期間の内に、オリ、沈殿物を発生するのみならず、
長期間の保存によって、過酸化脂質の生成に対して、そ
の能力が著しく低下し、まったく役立たない不安定なも
のも多いことである。For example, as introduced in the introduction, some lipid peroxides are known to have a suppressive effect, and the solution after extraction not only generates scum and precipitates within a short period of time, but also
When stored for a long period of time, its ability to generate lipid peroxide is significantly reduced, and many of them are completely useless and unstable.
つまり、凍結乾燥などの状態となし、密閉、低温保存さ
れたものにあっては5作用の低下は少ないが、゛それら
の活性成分を含んだ溶液や溶解液とした状態にあっては
、これを常温保存のもとで経時的に、その作用を求めて
みれば、その多(の抽出物は、低下する性質を有してい
ることが多いことであった・
例えば、SODの場合は、その特異性があるゆえに、そ
の活性の低下を示し、従って、これを具体的に化粧料の
処方中に利用しようとすれば、製剤化にあっては、未だ
多くの解決すべき問題点が残されていたわけであるが、
この点、本発明は、次表「第3表」に示すごとく、その
抽出溶液は、長期間保存されたものでも、はとんど作用
は低下せず、抜群の持続安定性が保持されることである
。In other words, if the product is stored in a state such as lyophilized, hermetically sealed, or at a low temperature, there is little decrease in the 5 effects, but if it is in a solution or dissolution solution containing those active ingredients, this When we investigated its effects over time under room temperature storage, we found that the extracts often had the property of deteriorating. For example, in the case of SOD, Because of its specificity, it shows a decrease in its activity, and therefore, if it is to be used specifically in the formulation of cosmetics, there are still many problems that remain to be solved in formulation. However,
In this regard, the present invention has the advantage that, as shown in the following table "Table 3", even when the extract solution is stored for a long period of time, its action hardly decreases and excellent long-term stability is maintained. That's true.
この持続安定性は、抽出の際の有機溶媒の選択とその組
合せのバランスにある。This sustained stability lies in the balance between the selection of organic solvents and their combination during extraction.
例えば、エタノールと同系の親水性の有機溶媒にあって
、メタノール、インプロパツールなどを用いても、作用
物質は抽出可能であるが、しかし、溶解安定性が著しく
低下し、過酸化脂質の生成に対する抑制作用について、
その持続性が悪いものとなる。For example, the active substance can be extracted using hydrophilic organic solvents similar to ethanol such as methanol and impropatul, but the solubility stability is significantly reduced and lipid peroxide is generated. Regarding the inhibitory effect on
Its sustainability will be poor.
尚、この点を具体的に示すために、第3表中には5本発
明で特定したと同様の原料をもとに。In order to specifically illustrate this point, Table 3 lists five samples based on the same raw materials as specified in the present invention.
一部の植物から、単独の有機溶媒による抽出物について
、これを−旦、凍結乾燥した後、水とエタノールの割合
が、5対5の混液中に溶かしたもの(第3表の検体欄中
の下段に、用いた溶媒を記ti)についても併記して示
した。Extracts from some plants using a single organic solvent were first freeze-dried and then dissolved in a mixture of water and ethanol at a ratio of 5:5 (in the sample column of Table 3). The solvents used are also shown in the lower part of ti).
すなわち、第3表からも理解できるように、抽出溶媒の
組合せは、抑制作用、オリ、沈殿などに大きく影響する
ことがわかる。That is, as can be understood from Table 3, the combination of extraction solvents has a large effect on the suppressing effect, sedimentation, precipitation, etc.
つまり、単なる抽出物では、クリームなどの乳化された
ものや、粉末状などのタイプの製剤に配合することは可
能であっても、透明状の液体製品1例えば、化粧水をは
じめ、シャンプー、リンスなどでは、オリや沈殿物の発
生を伴い、この時点で過酸化脂質の生成に対する抑制作
用も、急速に低下することである。In other words, even though it is possible to incorporate a simple extract into emulsified products such as creams or powdered preparations, transparent liquid products such as lotions, shampoos, conditioners, etc. In such cases, sludge and precipitates are generated, and at this point, the inhibitory effect on the production of lipid peroxide rapidly decreases.
又、第3表中、オリ、沈殿物の欄において。Also, in Table 3, in the columns of sludge and sediment.
O印は、その発生が認められなかったことを示し、印は
オリ、沈殿物が発生したことを示す。The O mark indicates that no such formation was observed, and the mark indicates that sludge or precipitate was formed.
(dl主成分についての検索
前記したA〜Hで特定した、それぞれの各抽出物の有す
る。過酸化脂質の生成抑制作用が、いかなる抽出物中の
成分によって達成されるのか、この点については、未だ
確定するまでには至っていない。(Search for dl main components contained in each of the extracts specified in A to H above. Regarding this point, what component in the extract achieves the effect of suppressing the production of lipid peroxides? It has not yet been confirmed.
しかし、それぞれの抽出物をもとに、主な成分を、分析
してみると、次表「第4表」に示すごとくの成分が、こ
れまでに確認されていることから、これらの成分は、有
力な関与物質の1つと推定される。However, when we analyze the main components based on each extract, we find that the components shown in Table 4 below have been confirmed so far. , is estimated to be one of the potentially involved substances.
「第4表」
抽出物に含有する主な確認成分
を有する。よって、例えば、広範囲にわたる製剤中に配
合でき、水を含むような処方中にあっても1分散剤(界
面活性剤)を用いなくても利用できることとなった。"Table 4" Contains the main confirmed components contained in the extract. Therefore, for example, it can be incorporated into a wide range of formulations, and even in formulations containing water, it can be used without using a dispersant (surfactant).
とくに、化粧品類には、従来の過酸化脂質生成に対する
抑制剤は、水を含む系中では不安定であったり、不溶性
であるものが多かったことから、充分な応用までには至
らなかったが、本発明による抑制剤であれば、第2〜3
表に示すごとくの安定性、持続した抑制作用からして理
解出来るように、化粧水などからクリームまで容易に配
合できるわけで、このことは、大きなメリットであると
いえる。In particular, conventional inhibitors of lipid peroxide production have not been fully applied to cosmetics because many of them are unstable or insoluble in systems containing water. , if it is an inhibitor according to the present invention, the second to third
As can be seen from the stability and sustained inhibitory effect shown in the table, it can be easily incorporated into everything from lotions to creams, which can be said to be a great advantage.
(ハ)発明の効果(c) Effects of the invention
Claims (1)
:チョウジ、E:ゲンノショウコ、F:アセンヤク、G
:オウバク、H:モモの葉を出発原料となし、そのA〜
Hのそれぞれに対する抽出溶媒が、次に示す混合溶媒を
用いて溶出された植物抽出物の内、その1種又は1種以
上を含有することを特徴とする、過酸化脂質生成抑制剤
。 [A〜Bに対する抽出溶媒] 水とエタノール、及び1,3−ブチレングリコールとの
割合が、5対3対2から3対3対4の混合溶媒を用いる
。 [C〜Gに対する抽出溶媒] 水とエタノールの割合が、7対3から4対6の混合溶媒
を用いる。 [Hに対する抽出溶媒] 水と1,3−ブチレングリコールの割合が、6対4から
3対7の混合溶媒を用いる。[Claims] [1] A: green tea or black tea, B: peony, C: mugwort, D
:Choji,E:Gennoshouko,F:Asenyaku,G
: Peach leaf, H: Using peach leaves as starting material, its A~
A lipid peroxide production inhibitor characterized in that the extraction solvent for each of H contains one or more of the plant extracts eluted using the following mixed solvents. [Extraction Solvent for A to B] A mixed solvent of water, ethanol, and 1,3-butylene glycol in a ratio of 5:3:2 to 3:3:4 is used. [Extraction solvent for C to G] A mixed solvent of water and ethanol in a ratio of 7:3 to 4:6 is used. [Extraction Solvent for H] A mixed solvent containing water and 1,3-butylene glycol in a ratio of 6:4 to 3:7 is used.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1064744A JP2802434B2 (en) | 1989-03-16 | 1989-03-16 | Lipid peroxide production inhibitor consisting of plant extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1064744A JP2802434B2 (en) | 1989-03-16 | 1989-03-16 | Lipid peroxide production inhibitor consisting of plant extract |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02243632A true JPH02243632A (en) | 1990-09-27 |
JP2802434B2 JP2802434B2 (en) | 1998-09-24 |
Family
ID=13266971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1064744A Expired - Fee Related JP2802434B2 (en) | 1989-03-16 | 1989-03-16 | Lipid peroxide production inhibitor consisting of plant extract |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2802434B2 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04300812A (en) * | 1991-03-29 | 1992-10-23 | Maruzen Pharmaceut Co Ltd | Costmetic |
JPH06107532A (en) * | 1992-09-28 | 1994-04-19 | Kao Corp | Cosmetic for fair skin and beauty |
JPH0717847A (en) * | 1993-06-30 | 1995-01-20 | Sansho Seiyaku Co Ltd | Skin external preparation |
FR2717382A1 (en) * | 1994-03-21 | 1995-09-22 | Fabre Pierre Cosmetique | Cosmetic compsns. contg. Paeonia lactiflora extract |
JPH0892055A (en) * | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetic |
JPH0892056A (en) * | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetic |
JPH10152428A (en) * | 1996-11-20 | 1998-06-09 | Kanebo Ltd | Skin preparation for external use |
JPH10182414A (en) * | 1996-12-27 | 1998-07-07 | Shiseido Co Ltd | Antiaging agent |
JPH10276719A (en) * | 1997-04-10 | 1998-10-20 | Yoshiharu Shoji | Vegetable functional food for preventing senile dementia |
JPH1112122A (en) * | 1997-06-20 | 1999-01-19 | Pola Chem Ind Inc | Skin-improving cosmetic |
JPH11206333A (en) * | 1991-12-19 | 1999-08-03 | Shichiro Niwano | Leaf processed food and its production |
JPH11292753A (en) * | 1998-04-14 | 1999-10-26 | Dowa Yakushou Kk | Agent for external use for head skin |
JP2000063237A (en) * | 1998-08-21 | 2000-02-29 | Kanebo Ltd | Lipolysis accelerant and skin cosmetic material for thin figure. |
JP2001048780A (en) * | 1999-08-10 | 2001-02-20 | Lion Corp | Stabilization of aqueous solution of vitamins and stable liquid vitamin preparation |
JP2001122765A (en) * | 2000-09-28 | 2001-05-08 | Naris Cosmetics Co Ltd | Active oxygen scavenger and cosmetic |
JP2001151630A (en) * | 1999-11-30 | 2001-06-05 | Kanebo Ltd | Cosmetic |
JP2002104921A (en) * | 2000-09-29 | 2002-04-10 | Pola Chem Ind Inc | Corium collagen fiber bundle-reconstituting agent and composition containing the same agent |
JP2005002057A (en) * | 2003-06-12 | 2005-01-06 | Ichimaru Pharcos Co Ltd | Material for beauty and health, containing extract of geranium robertianum |
JP2011057578A (en) * | 2009-09-08 | 2011-03-24 | Noevir Co Ltd | Peroxide lipid inhibitor and skin external preparation |
JP2017100991A (en) * | 2015-12-01 | 2017-06-08 | 花王株式会社 | Epidermis cml formation inhibitor |
CN107550965A (en) * | 2017-08-28 | 2018-01-09 | 杨凌萃健生物工程技术有限公司 | A kind of preparation method of Folium Artemisiae Argyi extract |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008195719A (en) * | 2007-01-19 | 2008-08-28 | Shonan Institute For Medical & Preventive Science | Inhibitor for blood sugar elevation |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4868717A (en) * | 1971-12-24 | 1973-09-19 | ||
JPS5936621A (en) * | 1982-08-25 | 1984-02-28 | Tsumura Juntendo Inc | Improving agent for cancerous symptom |
JPS59148712A (en) * | 1983-02-15 | 1984-08-25 | Kingo Yoshida | Cosmetic and drug containing tannin |
JPS6013780A (en) * | 1983-07-05 | 1985-01-24 | Mitsui Norin Kk | Production of tea catechin compound |
JPS6124522A (en) * | 1984-07-13 | 1986-02-03 | Kao Corp | Inhibitor composition for formation of skin peroxylipid |
-
1989
- 1989-03-16 JP JP1064744A patent/JP2802434B2/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4868717A (en) * | 1971-12-24 | 1973-09-19 | ||
JPS5936621A (en) * | 1982-08-25 | 1984-02-28 | Tsumura Juntendo Inc | Improving agent for cancerous symptom |
JPS59148712A (en) * | 1983-02-15 | 1984-08-25 | Kingo Yoshida | Cosmetic and drug containing tannin |
JPS6013780A (en) * | 1983-07-05 | 1985-01-24 | Mitsui Norin Kk | Production of tea catechin compound |
JPS6124522A (en) * | 1984-07-13 | 1986-02-03 | Kao Corp | Inhibitor composition for formation of skin peroxylipid |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04300812A (en) * | 1991-03-29 | 1992-10-23 | Maruzen Pharmaceut Co Ltd | Costmetic |
JPH11206333A (en) * | 1991-12-19 | 1999-08-03 | Shichiro Niwano | Leaf processed food and its production |
JPH06107532A (en) * | 1992-09-28 | 1994-04-19 | Kao Corp | Cosmetic for fair skin and beauty |
JPH0717847A (en) * | 1993-06-30 | 1995-01-20 | Sansho Seiyaku Co Ltd | Skin external preparation |
FR2717382A1 (en) * | 1994-03-21 | 1995-09-22 | Fabre Pierre Cosmetique | Cosmetic compsns. contg. Paeonia lactiflora extract |
JPH0892055A (en) * | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetic |
JPH0892056A (en) * | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetic |
JPH10152428A (en) * | 1996-11-20 | 1998-06-09 | Kanebo Ltd | Skin preparation for external use |
JPH10182414A (en) * | 1996-12-27 | 1998-07-07 | Shiseido Co Ltd | Antiaging agent |
WO1998029093A1 (en) * | 1996-12-27 | 1998-07-09 | Shiseido Company, Ltd. | Antiaging agent |
JPH10276719A (en) * | 1997-04-10 | 1998-10-20 | Yoshiharu Shoji | Vegetable functional food for preventing senile dementia |
JPH1112122A (en) * | 1997-06-20 | 1999-01-19 | Pola Chem Ind Inc | Skin-improving cosmetic |
JPH11292753A (en) * | 1998-04-14 | 1999-10-26 | Dowa Yakushou Kk | Agent for external use for head skin |
JP2000063237A (en) * | 1998-08-21 | 2000-02-29 | Kanebo Ltd | Lipolysis accelerant and skin cosmetic material for thin figure. |
JP2001048780A (en) * | 1999-08-10 | 2001-02-20 | Lion Corp | Stabilization of aqueous solution of vitamins and stable liquid vitamin preparation |
JP2001151630A (en) * | 1999-11-30 | 2001-06-05 | Kanebo Ltd | Cosmetic |
JP2001122765A (en) * | 2000-09-28 | 2001-05-08 | Naris Cosmetics Co Ltd | Active oxygen scavenger and cosmetic |
JP2002104921A (en) * | 2000-09-29 | 2002-04-10 | Pola Chem Ind Inc | Corium collagen fiber bundle-reconstituting agent and composition containing the same agent |
JP2005002057A (en) * | 2003-06-12 | 2005-01-06 | Ichimaru Pharcos Co Ltd | Material for beauty and health, containing extract of geranium robertianum |
JP2011057578A (en) * | 2009-09-08 | 2011-03-24 | Noevir Co Ltd | Peroxide lipid inhibitor and skin external preparation |
JP2017100991A (en) * | 2015-12-01 | 2017-06-08 | 花王株式会社 | Epidermis cml formation inhibitor |
CN107550965A (en) * | 2017-08-28 | 2018-01-09 | 杨凌萃健生物工程技术有限公司 | A kind of preparation method of Folium Artemisiae Argyi extract |
Also Published As
Publication number | Publication date |
---|---|
JP2802434B2 (en) | 1998-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH02243632A (en) | Peroxide lipid formation inhibitor comprising vegetable oil extract | |
JP2008044939A (en) | Slimming composition for cosmetic containing extract of biomass of alga neochloris oleoabundans | |
FR2896990A1 (en) | Composition useful in a topical cosmetic composition for skin e.g. to fight against skin-aging, comprises a dried vine shoot extract and ectoin ingredient | |
JPH035423A (en) | Lipid peroxide production-inhibiting agent containing flavonoid | |
JP5196416B2 (en) | Cosmetic composition containing Limnocitrus litoritalis extract | |
JPH0249710A (en) | Cosmetic | |
JP2009084169A (en) | Xanthone derivative exhibiting collagen-producing activity and method for producing the same | |
EP0866715A1 (en) | Combination of a myrtle extract and antifungal agents | |
JPS6236330A (en) | Swertia japonica herba extract and production thereof | |
JP3553477B2 (en) | Active oxygen scavenging enzyme activity promoter | |
JPH02264727A (en) | Peroxidized lipid production-inhibiting agent from plant extract | |
WO2014198789A1 (en) | Cosmetic composition having photoprotective properties | |
JPH06305978A (en) | Tyrosinase inhibitor, beautifying cosmetic and color change preventing agent | |
JP5819334B2 (en) | Synovial growth inhibitor | |
JP5991877B2 (en) | Cosmetics containing young leaf extract | |
JP2012171917A (en) | Astringent | |
JP2000327549A (en) | Cosmetic comprising extract of camu camu | |
KR20070052091A (en) | Natural antioxidant using oltmannsiellopsis unicellularis | |
JP2008031049A (en) | Anti-acne bacterium composition | |
Islam | In vitro evaluation of thrombolytic and antioxidant scavenging activity of eichhornia crassipes | |
US3133864A (en) | Hair and skin cosmetic and conditioner | |
TWI827537B (en) | Preparing method of cosmetic composition using skin cosmetic solution | |
JP7467116B2 (en) | Skin preparation containing extract of rose of the bank | |
JP2024066503A (en) | Antioxidant composition containing kabuchi peel extract and method for producing same | |
JP2000198726A (en) | Agent for suppressing formation of lipid peroxide and composition containing the agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313532 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313532 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070717 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080717 Year of fee payment: 10 |
|
LAPS | Cancellation because of no payment of annual fees |